Durvalumab (D) and PET-directed chemoradiation (CRT) after induction FOLFOX for esophageal adenocarcinoma Meeting Abstract
| Authors: | Ly, M.; Molena, D.; Sihag, S.; Wu, A. J. C.; Shah, P. M.; Gu, P.; Sugarman, R.; Maron, S. B.; Chalasani, S. B.; Shcherba, M.; Yeh, R.; Tang, L. H.; Alterman, C.; Collins, P.; Cowie, K.; Janjigian, Y. Y.; Ilson, D. H.; Ku, G. Y. |
| Abstract Title: | Durvalumab (D) and PET-directed chemoradiation (CRT) after induction FOLFOX for esophageal adenocarcinoma |
| Meeting Title: | 2020 Gastrointestinal Cancers Symposium |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 38 |
| Issue: | 4 Suppl. |
| Meeting Dates: | 2020 Jan 23-25 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2020-02-01 |
| Language: | English |
| ACCESSION: | WOS:000530922700378 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2020.38.4_suppl.394 |
| Notes: | Meeting Abstract: 394 -- Source: Wos |
